BioStock: Spotlight on MS
World MS Day will be celebrated on Sunday May 30th. It is a day to raise awareness of the condition, and to support and connect people living with the disease worldwide. Although over 2.5 million people are suffering from multiple sclerosis there is currently no treatment that is efficient across all patient groups. To fill this void the Swedish biotech company Cyxone is intensifying its efforts on their drug candidate, T20K, intended for a long-term MS treatment to stop disease progression, avoiding devastating side effects and more convenient to take compared to existing treatments.
Read the full article about the World MS Day and Cyxone at biostock.se:
https://www.biostock.se/2021/05/ms-i-stralkastarljuset/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/